| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.01 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.02 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.02 |